+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Oncogene"

Drug Delivery in Cancer - Technologies, Markets & Companies - Product Thumbnail Image

Drug Delivery in Cancer - Technologies, Markets & Companies

  • Report
  • November 2021
  • 747 Pages
  • Global
From
RNAi - Technologies, Markets & Companies - Product Thumbnail Image

RNAi - Technologies, Markets & Companies

  • Report
  • November 2021
  • 527 Pages
  • Global
From
Gene Therapy - Technologies, Markets & Companies - Product Thumbnail Image

Gene Therapy - Technologies, Markets & Companies

  • Report
  • November 2021
  • 802 Pages
  • Global
From
Personalized Medicine - Scientific & Commercial Aspects - Product Thumbnail Image

Personalized Medicine - Scientific & Commercial Aspects

  • Report
  • November 2021
  • 1165 Pages
  • Global
From
Holland-Frei Cancer Medicine. Edition No. 10 - Product Thumbnail Image

Holland-Frei Cancer Medicine. Edition No. 10

  • Book
  • April 2023
  • 2000 Pages
Fundamentals of Cancer Detection, Treatment, and Prevention. Edition No. 1 - Product Thumbnail Image

Fundamentals of Cancer Detection, Treatment, and Prevention. Edition No. 1

  • Book
  • June 2022
  • 496 Pages
Cancer Chemotherapy. Basic Science to the Clinic. Edition No. 2 - Product Thumbnail Image

Cancer Chemotherapy. Basic Science to the Clinic. Edition No. 2

  • Book
  • April 2020
  • 320 Pages
Anticancer Therapeutics. From Drug Discovery to Clinical Applications. Edition No. 1 - Product Thumbnail Image

Anticancer Therapeutics. From Drug Discovery to Clinical Applications. Edition No. 1

  • Book
  • February 2018
  • 448 Pages
Holland-Frei Cancer Medicine Cloth. Edition No. 9 - Product Thumbnail Image

Holland-Frei Cancer Medicine Cloth. Edition No. 9

  • Book
  • March 2017
  • 2008 Pages
Gene Therapy of Cancer. Translational Approaches from Preclinical Studies to Clinical Implementation. Edition No. 3 - Product Thumbnail Image

Gene Therapy of Cancer. Translational Approaches from Preclinical Studies to Clinical Implementation. Edition No. 3

  • Book
  • October 2013
Genomic and Epigenomic Biomarkers of Toxicology and Disease. Clinical and Therapeutic Actions. Edition No. 1 - Product Thumbnail Image

Genomic and Epigenomic Biomarkers of Toxicology and Disease. Clinical and Therapeutic Actions. Edition No. 1

  • Book
  • May 2022
  • 512 Pages
Abnormal Chromosomes. The Past, Present, and Future of Cancer Cytogenetics. Edition No. 1 - Product Thumbnail Image

Abnormal Chromosomes. The Past, Present, and Future of Cancer Cytogenetics. Edition No. 1

  • Book
  • March 2022
  • 208 Pages
Extracellular Targeting of Cell Signaling in Cancer. Strategies Directed at MET and RON Receptor Tyrosine Kinase Pathways. Edition No. 1 - Product Thumbnail Image

Extracellular Targeting of Cell Signaling in Cancer. Strategies Directed at MET and RON Receptor Tyrosine Kinase Pathways. Edition No. 1

  • Book
  • July 2018
  • 488 Pages
Toxicology and Epigenetics. Edition No. 1 - Product Thumbnail Image

Toxicology and Epigenetics. Edition No. 1

  • Book
  • September 2012
  • 688 Pages
Human Genetics and Genomics. A Practical Guide. Edition No. 1 - Product Thumbnail Image

Human Genetics and Genomics. A Practical Guide. Edition No. 1

  • Book
  • March 2020
  • 160 Pages
The Chemical Biology of DNA Damage. Edition No. 1 - Product Thumbnail Image

The Chemical Biology of DNA Damage. Edition No. 1

  • Book
  • June 2010
  • 471 Pages
Epigenetics and Metabolomics. Translational Epigenetics Volume 28 - Product Thumbnail Image

Epigenetics and Metabolomics. Translational Epigenetics Volume 28

  • Book
  • August 2021
Integration and Visualization of Gene Selection and Gene Regulatory Networks for Cancer Genome - Product Thumbnail Image

Integration and Visualization of Gene Selection and Gene Regulatory Networks for Cancer Genome

  • Book
  • May 2018
Loading Indicator

The Oncogene market is a subset of the Genomics market that focuses on the study of cancer-causing genes. Oncogenes are genes that have the potential to cause cancer when they are mutated or expressed at high levels. Oncogenes are studied to understand the molecular basis of cancer and to develop new treatments. Research in this field has led to the development of targeted therapies, such as monoclonal antibodies, small molecule inhibitors, and gene therapies. The Oncogene market is highly competitive, with many companies developing new technologies and treatments. Companies in the market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, and Bio-Rad Laboratories. Show Less Read more